Bempedoic Acid

6 trials 1 recruiting CCardiology

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

1 Recruiting

4 Completed trials

6 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 3 Phase II: 1 Phase IV: 2

Oversight events:

4 temporary halts across 1 trial

View oversight register →

Indications tested

Hypercholesterolaemia 1

Sponsors using this IMP

A. Menarini International Licensing S.A. 1 Esperion Therapeutics Inc. 1 Instituto De Investigacion Marques De Valdecilla 1 Medizinische Hochschule Hannover 1 Merck Sharp & Dohme LLC 1 Novartis Pharma AG 1

All trials

6 total

Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with … Pending

2025-521086-28-00 Phase IV 1 country Instituto De Investigacion Marques De Valdecilla
Obicetrapib Versus Bempedoic Acid to Treat Dyslipidemia in Patients at High to Very High Cardiovascular Risk Recruiting

2025-524265-24-00 Phase III 7 countries A. Menarini International Licensing S.A.
HAnnover ChOlesterol Lowering study in ACS Ended

2024-513703-13-00 Phase III 1 country Medizinische Hochschule Hannover
A Phase 2 Clinical Study in Children With HeFH Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1) Ended

2024-515864-30-00 Phase II 4 countries Esperion Therapeutics Inc.
MK-0616 versus Comparators Study in Adults with Hypercholesterolemia Ended

2023-504920-25-00 Phase III 2 countries Merck Sharp & Dohme LLC
A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended

2024-511076-32-00 Phase IV 1 country Novartis Pharma GmbH

Showing 1–6 of 6 trials

← All drugs A–Z